Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Oct;52(10):2411–2417. doi: 10.1172/JCI107431

Comparative Pharmacology of Δ9-Tetrahydrocannabinol and its Metabolite, 11-OH-Δ9-Tetrahydrocannabinol

Louis Lemberger 1,2,3, Robert Martz 1,2,3, Bruce Rodda 1,2,3, Robert Forney 1,2,3, Howard Rowe 1,2,3
PMCID: PMC302499  PMID: 4729039

Abstract

A comparison of the psychologic and physiologic effects of intravenously administered Δ9-tetrahydrocannabinol (Δ9-THC) and 11-hydroxy-Δ9-tetrahydrocannabinol (11-OH-Δ9-THC) was carried out in nine casual marihuana smokers. A marked tachycardia and psychologic “high” occurred within 3-5 min after the i.v. administration of 11-OH-Δ9-THC (1 mg) to all subjects. In contrast, the peak psychologic “high” was delayed 10-20 min after the i.v. administration of Δ9-THC (1 mg). There was some individual variation in response among subjects. Psychologic effects correlated well with plasma levels of unchanged [3H]11-OH-Δ9-THC. About 75% of the administered radioactive dose was excreted in urine (25%) and feces (50%) after [3H]11-OH-Δ9-THC administration. The disposition, excretion, and metabolism of [3H]11-OH-Δ9-THC appear to be similar to that previously reported after [14C]Δ9-THC administration. These findings, in conjunction with the marked psychologic high seen after 11-OH-Δ9-THC, suggest that in man, Δ9-THC, the active constituent in marihuana, is converted to 11-OH-Δ9-THC, which is in part responsible for the psychologic effects.

Full text

PDF
2411

Images in this article

2415Image
on p.2415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Zvi Z., Mechoulam R., Burstein S. Identification through synthesis of an active delta-1(6)-tetrahydrocannabinol metabolite. J Am Chem Soc. 1970 Jun 3;92(11):3468–3469. doi: 10.1021/ja00714a043. [DOI] [PubMed] [Google Scholar]
  2. Christensen H. D., Freudenthal R. I., Gidley J. T., Rosenfeld R., Boegli G., Testino L., Brine D. R., Pitt C. G., Wall M. E. Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse. Science. 1971 Apr 9;172(3979):165–167. doi: 10.1126/science.172.3979.165. [DOI] [PubMed] [Google Scholar]
  3. Foltz R. L., Fentiman A. F., Jr, Leighty F. G., Walter J. L., Drewes H. R., Schwartz W. E., Page T. F., Jr, Truitt E. B., Jr Metabolite of (-)-trans-delta 8-tetrahydrocannabinol: identification and synthesis. Science. 1970 May 15;168(3933):844–845. doi: 10.1126/science.168.3933.844. [DOI] [PubMed] [Google Scholar]
  4. Hollister L. E., Richards R. K., Gillespie H. K. Comparison of tetrahydrocannabinol and synhexyl in man. Clin Pharmacol Ther. 1968 Nov-Dec;9(6):783–791. doi: 10.1002/cpt196896783. [DOI] [PubMed] [Google Scholar]
  5. Isbell H., Gorodetzsky C. W., Jasinski D., Claussen U., von Spulak F., Korte F. Effects of (--)delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia. 1967;11(2):184–188. doi: 10.1007/BF00401256. [DOI] [PubMed] [Google Scholar]
  6. Lemberger L., Axelrod J., Kopin I. J. Metabolism and disposition of delta-9-tetrahydrocannabinol in man. Pharmacol Rev. 1971 Dec;23(4):371–380. [PubMed] [Google Scholar]
  7. Lemberger L., Silberstein S. D., Axelrod J., Kopin I. J. Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man. Science. 1970 Dec 18;170(3964):1320–1322. doi: 10.1126/science.170.3964.1320. [DOI] [PubMed] [Google Scholar]
  8. Lemberger L., Weiss J. L., Watanabe A. M., Galanter I. M., Wyatt R. J., Cardon P. V. Delta-9-tetrahydrocannabinol. Temporal correlation of the psychologic effects and blood levels after various routes of administration. N Engl J Med. 1972 Mar 30;286(13):685–688. doi: 10.1056/NEJM197203302861303. [DOI] [PubMed] [Google Scholar]
  9. Mechoulam R. Marihuana chemistry. Science. 1970 Jun 5;168(3936):1159–1166. doi: 10.1126/science.168.3936.1159. [DOI] [PubMed] [Google Scholar]
  10. Nilsson I. M., Agurell S., Nilsson J. L., Ohlsson A., Sandberg F., Wahlqvist M. Delta-1-tetrahydrocannabinol: structure of a major metabolite. Science. 1970 Jun 5;168(3936):1228–1229. doi: 10.1126/science.168.3936.1228. [DOI] [PubMed] [Google Scholar]
  11. Perez-Reyes M., Timmons M. C., Lipton M. A., Davis K. H., Wall M. E. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol. Science. 1972 Aug 18;177(4049):633–635. doi: 10.1126/science.177.4049.633. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES